Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
An Introduction to NMR-Based Metabolomics at the UNC Metabolomics Laboratory
NONAME00
9 8 7 6 5 4 3 2 1Chemical Shift (ppm)
Tom O’Connell, Ph.D. Director & Associate Prof. Pharmacotherapy
The Definition of Metabonomics
The quantitative measurement of metabolic responses in biological fluids, cells or tissues to pathophysiological stimuli.
Adapted from Nicholson and Wilson, Nature Reviews in Drug Discovery, 2, 668, 2003
Metabolomics vs. Metabonomics?
Don’t’ worry about it.
Analytical Coverage of the Metabolome
Adapted from Sumner, LW, et al., Phytochem, 62, 817,2003
NMR
LC/UV
GC/MS
LC/MS
µM (10-6)
nM (10-9)
pM (10-12)
fM (10-15)
Main Analytical Approaches to Metabolomics
MS
Chromatography
LC/MS
GC/MS
CE/MS
NMR
LC/NMR
Off-linehyphenation
Pros & Cons of NMR-Based Metabolomics
• Comprehensive profiling by a single non-destructive method
• Inherently quantitative signals
• Minimal sample preparation
• Very high information content for structure elucidation (stereo/regiochemistry)
• Very high long term intra/inter-lab reproducibility
• Relatively insensitive; concentrations in low µ-mole
• Spectral crowding necessitates advanced methods (2D, 1H-13C) on some samples
• NMR spectral data libraries are growing, but still relatively small
Pros Cons
UNC Metabolomic Laboratory
600MHz Magnet Tube-based Automation Robot
Fluidic sample system & flow
probe
Sensitivity & Resolution
950
• Sensitivity increases as B3/2• Resolution increases linearly• Cold probe adds ~ 3-4 fold sensitivity
0
2
4
6
8
10
12
14
400 500 600 700 800 950
Field Strength (MHz)
Rel
ativ
e S
ensi
tivity
(400
MH
z)
Micro-coil NMR System
10 - 20 µl>500 µl
• Sample volumes of 10 µl • Urine & serum analyzed in ~ 25
minutes w/out concentration• Sensitivity gains with
concentration• Fully automated data collection• Sample returned to vial/plate
after data collection
Protasis High-throughput Sample System
Temperature controlled sample stack for up to 6 plates
Automated syringe injection from vials
In-line filters and reverse rinse protocols minimize clogs from biofluids
Sampling format is customizable allowing the use of multiple types of vials or microplates
Magic Angle Spinning NMR for Profiling of Intact Tissue
Yang et al., J. Proteome Res. 6, 2605, 2007
HR-MASNMR
In vitroextracts
Bo
Typical Urine NMR Spectrum
9 8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
Hundreds/thousands of peaks corresponding to hundreds/thousands
of metabolites
Typical Urine NMR Spectrum
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5Chemical Shift (ppm)
What types of samples can we look at?
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
Human serum
What types of samples can we look at?
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
Human bronchoalveolarlavage fluid
What types of samples can we look at?
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
Human CSF
Metabolomics Involves Many Samples
Looking for subtle differences in many spectra requires some data reduction/simplification
NONAME00
9 8 7 6 5 4 3 2 1Chemical Shift (ppm)
Data Reduction
Variables (chemical shift bins)
Sam
ples
Each sample is described by ~ 200 variablesReduce the data by capturing the variance with combinations of variables
(ppm) File Name [0.50 .. 0.53] [0.53 .. 0.59] [0.59 .. 0.61] [0.61 .. 0.63] [0.63 .. 0.66] [0.66 .. 0.69] [0.69 .. 0.72] [0.72 .. 0.75] [0.75 .. 0.79] [0.79 .. 0.81] [0.81 .. 0.83] [0.83 .. 0.85] [0.85 .. 0.91 3 s01_d01 2.04 4.20 1.88 1.60 2.17 2.08 2.42 2.64 2.83 1.80 1.76 2.01 9.754 s01_d03 2.15 4.38 1.95 1.68 2.25 2.19 2.51 2.69 2.81 1.82 1.81 2.00 9.625 s01_d05 2.37 4.81 2.18 1.85 2.47 2.38 2.75 2.88 3.05 1.98 1.95 2.10 9.366 s01_d07 2.47 4.97 2.26 1.91 2.54 2.45 2.83 3.03 3.18 2.01 1.98 2.13 8.917 s02_d01 2.12 4.42 1.94 1.66 2.24 2.15 2.52 2.70 2.85 1.86 1.83 2.15 10.268 s02_d03 2.29 4.73 2.15 1.81 2.42 2.35 2.71 2.93 3.04 1.99 2.01 2.25 10.069 s02_d05 2.36 4.85 2.19 1.87 2.46 2.37 2.76 2.91 3.04 1.98 1.95 2.11 9.0510 s02_d07 2.41 4.86 2.20 1.89 2.50 2.40 2.80 2.94 3.07 1.99 1.97 2.14 8.8811 s03_d01 2.39 4.88 2.22 1.88 2.52 2.48 2.87 3.22 3.56 2.20 2.17 2.58 11.1112 s03_d03 2.41 4.88 2.22 1.89 2.58 2.48 2.89 3.19 3.45 2.15 2.12 2.47 10.6213 s03_d05 2.43 4.92 2.24 1.91 2.56 2.47 2.88 3.17 3.38 2.14 2.06 2.32 9.4114 s03_d07 2.38 4.83 2.20 1.87 2.50 2.43 2.83 3.18 3.41 2.09 2.02 2.26 9.4215 s04_d01 2.43 5.00 2.21 1.89 2.57 2.51 2.89 3.22 3.49 2.21 2.16 2.54 11.1816 s04_d03 2.53 5.20 2.35 2.00 2.67 2.57 3.05 3.36 3.61 2.27 2.21 2.51 10.7917 s04_d05 2.85 5.58 2.51 2.12 2.94 2.84 3.28 3.45 3.63 2.31 2.27 2.43 8.8418 s04_d07 2.74 5.49 2.45 2.11 2.83 2.79 3.17 3.45 3.63 2.32 2.24 2.46 9.8519 s05_d01 2.24 4.71 2.14 1.82 2.44 2.43 2.78 3.06 3.48 2.20 2.09 2.52 11.4320 s05_d03 2.35 4.85 2.22 1.89 2.51 2.57 2.96 3.25 3.56 2.26 2.19 2.52 10.6821 s05_d05 2.44 4.98 2.27 1.93 2.59 2.52 2.88 3.09 3.28 2.13 2.05 2.26 9.0422 s05_d07 2.42 4.91 2.21 1.92 2.55 2.49 2.88 3.11 3.35 2.14 2.12 2.19 9.4823 s06_d01 2.77 5.63 2.51 2.15 2.94 2.86 3.31 3.58 3.73 2.39 2.42 2.77 11.4924 s06_d03 2.89 5.92 2.66 2.30 3.04 2.98 3.47 3.63 3.82 2.50 2.50 2.71 10.8425 s06_d05 3.09 6.24 2.80 2.41 3.18 3.12 3.57 3.78 3.97 2.59 2.55 2.76 10.6026 s06_d07 3.01 6.05 2.71 2.34 3.11 3.01 3.50 3.69 3.89 2.53 2.50 2.75 10.6727 s07_d01 2.89 5.81 2.58 2.23 3.02 2.94 3.36 3.66 3.85 2.51 2.49 2.75 11.3828 s07_d03 2.79 5.71 2.53 2.22 2.91 2.83 3.29 3.55 3.78 2.43 2.42 2.70 11.0229 s07_d05 3.00 6.05 2.71 2.31 3.08 3.01 3.47 3.73 3.91 2.53 2.46 2.70 10.3830 s07_d07 2.87 5.85 2.62 2.27 2.99 2.89 3.39 3.60 3.73 2.46 2.46 2.57 10.2231 s08_d01 2.04 4.21 1.86 1.66 2.19 2.13 2.48 2.77 2.99 1.91 1.89 2.16 10.8632 s08_d03 2.35 4.82 2.19 1.89 2.55 2.49 2.89 3.30 3.54 2.22 2.23 2.48 11.5033 s08_d05 2.60 5.27 2.41 2.07 2.75 2.68 3.09 3.34 3.51 2.25 2.25 2.40 9.8034 s08_d07 2.39 4.88 2.24 1.89 2.54 2.48 2.87 3.11 3.35 2.15 2.12 2.27 9.9639 s10_d01 2.37 4.84 2.18 1.87 2.53 2.41 2.80 2.99 3.14 2.07 2.07 2.22 10.0140 s10_d03 2.44 5.02 2.30 1.94 2.63 2.55 2.94 3.11 3.26 2.12 2.13 2.21 10.0741 s10_d05 2.76 5.57 2.55 2.14 2.89 2.78 3.16 3.42 3.54 2.29 2.21 2.33 9.0542 s10_d07 2.70 5.46 2.49 2.10 2.79 2.73 3.19 3.38 3.50 2.23 2.19 2.33 9.0743 s11_d01 2.28 4.72 2.10 1.79 2.44 2.40 2.82 3.00 3.19 2.05 2.03 2.39 10.4544 s11_d03 2.54 5.20 2.39 1.98 2.66 2.62 3.09 3.25 3.44 2.21 2.18 2.46 10.20
Serum Metabolomics Analysis from Binned Data
-6
-4
-2
0
2
4
6
-9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9
t[2]
t[1]
tmoc_101_a.M4 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M4
R2X[1] = 0.378319 R2X[2] = 0.267475 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 11/21/2007 3:43:14 AM
-6
-4
-2
0
2
4
6
-9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9
t[2]
t[1]
tmoc_101_a.M4 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M4
R2X[1] = 0.378319 R2X[2] = 0.267475 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 11/21/2007 3:43:14 AM
MD
Effects of methyl donor rich diet (choline, betaine, folic acid) on high dose ethanol consuption
Tools to Identify Biomarkers
Set of 1D1H spectra
2D spectra1H & 13C
NMRDatabase
1H & 13CPrediction
KEGG Analysis
MetaboliteID
Quantitative Fitting with NMR Database
The Human Metabolome Database
http://www.metabolomics.ca/
1
2,3
21
5 4
6
7
89
14
11
13
15
17,18,19
20
1612
5
7
17
10 1
2,3
21
5 4
6
7
89
14
11
13
15
17,18,19
20
1612
5
7
17
10
Metabolite ID with 2D Datasets1H-1H or 1H-13C correlation spectra on selected samples
1 = terminal methyl groups of low density (LDL) and very low density lipoproteins (VLDL). 2 = valine. 3 = leucine. 4 = 3-hydroxybutyrate. 5 = lactate. 6 = methylene protons of LDL and VLDL. 7 = alanine. 8 = methylene protons of C3 of VLDL lipoproteins. 9 = allylic methylenes of lipoproteins. 10 = acetate. 11 = N-acetylated glyoproteins. 12 = methylene protons of C2 of VLDL. 13 = methylene protons between olefinic groups of lipoproteins. 14 = albumin lysyl methylene groups. 15 = phospholipid choline headgroups. 16 = taurine. 17 = glucose. 18 = glycerol. 19 = amino acid Ca protons. 20 = choline. 21 = methylene groups of phosphatidylethanolamines.
Targetted Metabolomics
Perform quantitative fitting on all critical metabolites and use this data for statistical analysis
-40
-30
-20
-10
0
10
20
30
40
-50 -40 -30 -20 -10 0 10 20 30 40 50
t[2]
t[1]
All_conc_targetted.M3 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M3
R2X[1] = 0.453432 R2X[2] = 0.246049 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 2/4/2008 1:26:37 PM
HFD+MD
HFD+MD+EtOH
HFD
HFD+EtOH
Serum Metabolomics Analysis from Targetted Metabolite Profiles
MD
EtOH
Moving from Global to Targeted Metabolomics
-6
-4
-2
0
2
4
6
-9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9
t[2]
t[1]
tmoc_101_a.M4 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M4
R2X[1] = 0.378319 R2X[2] = 0.267475 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 11/21/2007 3:43:14 AM
-6
-4
-2
0
2
4
6
-9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9
t[2]
t[1]
tmoc_101_a.M4 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M4
R2X[1] = 0.378319 R2X[2] = 0.267475 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 11/21/2007 3:43:14 AM
-0.1
0.0
0.1
0.2
0.3
-0.2 -0.1 -0.0 0.1 0.2 0.3
p[2]
p[1]
Rusyn_all_integ.M1 (PCA-X)p[Comp. 1]/p[Comp. 2]Colored according to model terms
R2X[1] = 0.903587 R2X[2] = 0.0421382
[9.40 .. 9[9.38 .. 9[9.35 .. 9[9.33 .. 9[9.31 .. 9[9.25 .. 9[9.23 .. 9[9.21 .. 9[9.19 .. 9[9.13 .. 9[9.11 .. 9[9.09 .. 9[9.03 .. 9[8.99 .. 9[8.93 .. 8[8.90 .. 8
[8.85 .. 8[8.83 .. 8[8.78 .. 8[8.74 .. 8[8.70 .. 8[8.68 .. 8[8.63 .. 8
[8.60 .. 8[8.58 .. 8[8.52 .. 8[8.47 .. 8[8.44 .. 8[8.42 .. 8[8.40 .. 8[8.37 .. 8[8.32 .. 8[8.26 .. 8[8.23 .. 8[8.18 .. 8
[8.16 .. 8[8.13 .. 8
[8.07 .. 8[8.01 .. 8[7.95 .. 8[7.93 .. 7[7.91 .. 7[7.85 .. 7[7.81 .. 7[7.79 .. 7[7.76 .. 7[7.71 .. 7
[7.66 .. 7[7.61 .. 7
[7.55 .. 7[7.49 .. 7[7.46 .. 7
[7.40 .. 7[7.34 .. 7[7.29 .. 7
[7.24 .. 7[7.20 .. 7
[7.14 .. 7[7.12 .. 7
[7.10 .. 7[7.07 .. 7[7.02 .. 7[6.99 .. 7
[6.93 .. 6
[6.88 .. 6[6.83 .. 6
[6.80 .. 6[6.77 .. 6[6.75 .. 6[6.73 .. 6[6.70 .. 6[6.64 .. 6[6.62 .. 6[6.60 .. 6[6.58 .. 6[6.55 .. 6[6.51 .. 6[6.47 .. 6[6.45 .. 6[6.40 .. 6[4.25 .. 4
[4.21 .. 4[4.18 .. 4[4.13 .. 4
[4.07 .. 4 [4.02 .. 4
[3.97 .. 4
[3.92 .. 3
[3.86 .. 3
[3.82 .. 3
[3.79 .. 3
[3.74 .. 3
[3.69 .. 3
[3.67 .. 3[3.65 .. 3[3.63 .. 3
[3.61 .. 3[3.59 .. 3
[3.56 .. 3
[3.54 .. 3[3.48 .. 3
[3.46 .. 3
[3.40 .. 3
[3.37 .. 3
[3.31 .. 3
[3.26 .. 3
[3.24 .. 3
[3.22 .. 3
[3.19 .. 3[3.13 .. 3[3.09 .. 3[3.07 .. 3
[3.02 .. 3
[3.00 .. 3[2.98 .. 3[2.96 .. 2[2.94 .. 2[2.92 .. 2
[2.87 .. 2 [2.85 .. 2[2.81 .. 2
[2.77 .. 2[2.71 .. 2
[2.69 .. 2[2.66 .. 2
[2.60 .. 2
[2.55 .. 2[2.51 .. 2[2.46 .. 2[2.43 .. 2
[2.37 .. 2[2.32 .. 2[2.27 .. 2
[2.25 .. 2[2.20 .. 2[2.18 .. 2
[2.16 .. 2
[2.11 .. 2[2.08 .. 2
[2.02 .. 2
[2.00 .. 2[1.98 .. 2[1.95 .. 1
[1.90 .. 1[1.86 .. 1[1.80 .. 1
[1.75 .. 1[1.70 .. 1
[1.66 .. 1
[1.60 .. 1
[1.58 .. 1[1.56 .. 1[1.54 .. 1[1.52 .. 1
[1.47 .. 1
[1.45 .. 1[1.40 .. 1[1.35 .. 1
[1.31 .. 1
[1.27 .. 1
[1.25 .. 1
[1.20 .. 1[1.18 .. [1.15 .. 1[1.13 .. 1
[1.10 .. 1[1.07 .. 1[1.03 .. 1
[0.97 .. 1[0.91 .. 0
[0.87 .. 0
[0.84 .. 0[0.82 .. 0[0.80 .. 0
[0.76 .. 0[0.74 .. 0
[0.68 .. 0
[0.66 .. 0[0.64 .. 0[0.62 .. 0[0.60 .. 0[0.58 .. 0[0.56 .. 0[0.54 .. 0[0.51 .. 0[0.46 .. 0
[0.44 .. 0[0.42 .. 0[0.40 .. 0[0.38 .. 0[0.35 .. 0[0.33 .. 0[0.29 .. 0[0.25 .. 0
SIMCA-P+ 11.5 - 2/7/2008 9:25:21 AM
Higher inEtOH
Higher in Controls
Global models show separation
Loadings guide metabolite ID
-40
-30
-20
-10
0
10
20
30
40
-50 -40 -30 -20 -10 0 10 20 30 40 50
t[2]
t[1]
All_conc_targetted.M3 (PCA-X)t[Comp. 1]/t[Comp. 2]Colored according to classes in M3
R2X[1] = 0.453432 R2X[2] = 0.246049 Ellipse: Hotelling T2 (0.95)
Class 1Class 2Class 3Class 4
SIMCA-P+ 11.5 - 2/4/2008 1:26:37 PM
HFD+MD
HFD+MD+EtOH
HFD
HFD+EtOH
-0.1
0.0
0.1
0.2
-0.1 0.0 0.1 0.2
p[2]
p[1]
All_conc_targetted.M3 (PCA-X)p[Comp. 1]/p[Comp. 2]Colored according to model terms
R2X[1] = 0.453432 R2X[2] = 0.246049
Choline
O-Phosphoc
N,N-Dimeth
Carnitine
CitrateTrimethyla
Creatine
CreatinineAlanine
GlutamateGlutamine
Glycine
LysineThreonine
Valine
glyco-prot
glyceryl/c
LDL &VLDL
lipidslipids1
SIMCA-P+ 11.5 - 2/4/2008 1:32:39 PM
HFD+EtOHHFD+MD+EtOH
HFD+MD HFD
Targeted model improves separation
Targeted loadings guide interpretation
2.02.53.03.54.04.5 2.12.22.32.42.62.72.82.93.13.23.33.43.63.73.83.94.14.24.34.4
129S1-SvImJ vs DBA-2J TCE
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
DBA-2J
129-SvImJ
Lactate
Choline phospho-choline betaine
Glutathione
Glutamate
Sugar Region
7.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.88.99.0
129S1-SvImJ vs DBA-2J TCE
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
DBA-2J
129-SvImJ
Formate
Adenosine
Adenine PheNiacinamidenicotinate
UridineTyr
0.80.91.01.1 0.850.951.05
129S1-SvImJ vs DBA-2J TCE
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
DBA-2J
129-SvImJ
Val Leu
Ileu
OPLS Loadings Plot for Metabolite ID
Peak intensity relates to importance in discriminating the groups
Color relates to the confidence in the model
DBA/2J
129-SvlmJ
Combining Global Metabolomics with Targeted Metabolite Assays
non-responders phenotype 1 phenotype 2
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
DC
A C
onc.
(uM
)
16 strain inbred mouse panel of acute trichloroethylene (TCE) dosing
Global metabolomics identifies two responder “metabotypes” (global NMR)
Responder metabotypes have distinct levels of DCA metabolite (targetted MS)
Heat map of NMR spectra DCA Levels by Targeted LC/MS
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
NMR spectra4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
High throughput collection
1 [0.50 .. 0.52] 1.1 1.0 1.1 1.0 1.1 1.0 1.1 1.0 1.0 1.1 1.1 1.0 1.1 1.1 1.1 1.1 1.4 1.12 [0.52 .. 0.55] 1.1 1.0 1.1 0.9 1.1 1.0 1.1 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.4 1.13 [0.55 .. 0.59] 1.9 1.7 1.9 1.7 1.9 1.8 1.9 1.8 1.7 1.9 2.0 1.8 1.9 1.9 1.9 1.9 2.4 1.84 [0.59 .. 0.61] 1.1 0.9 1.0 0.9 1.1 1.0 1.0 1.0 0.9 1.1 1.1 1.0 1.0 1.0 1.1 1.0 1.3 1.05 [0.61 .. 0.64] 1.2 1.0 1.2 1.0 1.2 1.1 1.2 1.1 1.1 1.2 1.2 1.1 1.2 1.2 1.2 1.1 1.5 1.16 [0.64 .. 0.66] 1.0 0.9 1.0 0.9 1.0 1.0 1.0 0.9 0.9 1.0 1.0 0.9 1.0 1.0 1.0 1.0 1.2 1.07 [0.66 .. 0.68] 1.1 0.9 1.1 0.9 1.1 1.0 1.0 1.0 0.9 1.1 1.1 1.0 1.1 1.0 1.1 1.0 1.3 1.08 [0.68 .. 0.70] 1.1 0.9 1.0 0.9 1.1 1.0 1.0 1.0 0.9 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.3 1.09 [0.70 .. 0.72] 1.2 1.0 1.1 1.0 1.2 1.1 1.1 1.1 1.0 1.1 1.2 1.1 1.1 1.1 1.2 1.3 1.4 1.1
10 [0.72 .. 0.74] 1.1 0.9 1.1 1.1 1.2 1.3 1.0 1.0 0.9 1.1 1.1 1.0 1.1 1.0 1.1 1.4 1.3 1.111 [0.74 .. 0.76] 1.1 0.9 1.1 1.1 1.3 1.5 1.1 1.1 0.9 1.1 1.1 1.0 1.1 1.1 1.1 1.2 1.4 1.112 [0.76 .. 0.78] 1.3 1.1 1.3 1.1 1.4 1.5 1.2 1.2 1.1 1.3 1.3 1.2 1.3 1.2 1.3 1.2 1.5 1.213 [0.78 .. 0.80] 1.3 1.0 1.2 1.1 1.4 1.4 1.1 1.1 1.0 1.2 1.2 1.1 1.3 1.2 1.2 1.2 1.5 1.214 [0.80 .. 0.82] 1.6 1.2 1.4 1.9 2.0 2.2 1.3 1.4 1.1 1.5 1.3 1.2 1.6 1.3 1.4 1.6 1.7 1.415 [0.82 .. 0.88] 12.9 12.0 11.3 16.9 21.4 20.2 9.5 13.1 10.2 11.9 9.6 10.8 12.5 11.1 9.8 8.6 13.2 10.616 [0.88 .. 0.94] 6.9 8.4 6.2 6.7 8.5 6.7 5.4 5.3 5.3 8.2 5.8 6.2 6.4 5.3 6.3 5.4 8.3 6.217 [0.94 .. 0.99] 6.5 7.3 6.3 5.5 6.0 6.2 5.9 5.6 5.8 7.4 6.9 6.9 6.2 5.8 7.3 6.2 9.2 6.418 [0.99 .. 1.05] 5.1 4.9 4.9 3.8 4.4 4.5 4.6 4.3 4.2 5.3 5.0 4.8 4.7 4.5 5.2 4.2 6.4 4.719 [1.05 .. 1.07] 2.1 2.0 2.1 1.4 1.8 1.7 1.9 1.7 1.7 2.3 2.2 2.0 2.0 1.9 2.2 1.6 2.7 1.920 [1.07 .. 1.10] 1.6 1.2 1.5 1.1 1.5 1.5 1.4 1.3 1.1 1.5 1.5 1.2 1.5 1.3 1.6 1.3 1.8 1.421 [1.10 .. 1.12] 1.5 0.9 1.5 1.1 1.5 1.4 1.3 1.3 0.9 1.3 1.3 1.1 1.4 1.2 1.4 1.2 1.6 1.322 [1.12 .. 1.15] 5.0 2.9 4.5 5.1 6.0 8.2 4.2 4.8 3.3 3.7 3.8 3.2 4.4 4.2 4.2 5.1 4.7 4.423 [1.15 .. 1.20] 137.8 84.6 126.5 83.3 76.6 113.7 110.6 128.4 110.0 80.4 83.7 84.8 98.2 110.6 101.1 99.6 107.2 113.424 [1.20 .. 1.22] 6.5 5.4 5.0 2.8 2.8 2.2 4.7 4.2 10.4 6.7 5.6 5.3 4.2 4.9 6.2 2.1 6.9 6.625 [1.22 .. 1.24] 1.9 2.2 1.8 2.8 3.1 3.2 1.7 1.8 2.0 2.0 1.6 2.1 2.0 1.7 1.6 1.6 2.3 1.926 [1.24 .. 1.26] 2.6 2.7 2.3 5.0 6.1 5.8 2.0 2.2 2.0 2.7 2.0 2.3 2.7 2.0 2.0 2.0 2.8 2.327 [1.26 .. 1.30] 6.8 9.1 5.5 12.9 19.8 12.0 4.7 5.8 4.6 9.0 4.8 5.7 7.2 4.9 5.4 4.7 7.7 5.628 [1.30 .. 1.35] 59.0 80.7 57.1 56.6 60.6 59.9 65.7 75.5 61.4 70.6 73.8 74.9 63.7 67.7 68.6 54.6 82.2 60.029 [1.35 .. 1.39] 2.2 4.0 2.2 3.0 2.9 2.5 2.4 2.5 3.2 2.8 2.4 3.4 2.3 2.4 2.1 2.5 3.4 2.430 [1.39 .. 1.43] 2.4 3.1 2.4 2.8 2.5 2.8 2.5 2.7 2.7 2.6 2.5 3.0 2.5 2.5 2.3 2.9 3.4 2.531 [1.43 .. 1.49] 3.8 5.5 3.7 5.6 5.2 5.7 4.0 4.0 4.3 5.1 4.6 5.3 4.3 4.2 4.8 4.0 6.3 4.432 [1.49 .. 1.51] 1.3 1.9 1.3 1.5 1.5 1.8 1.4 1.6 1.5 2.1 1.8 2.4 1.5 1.5 1.5 1.3 2.0 1.433 [1.51 .. 1.56] 5.2 5.6 4.7 7.2 7.9 10.0 5.4 7.9 5.8 5.4 5.3 5.9 5.9 6.5 4.8 4.7 7.0 5.534 [1.56 .. 1.62] 2.8 3.7 2.8 3.3 3.7 3.2 3.1 3.3 3.6 3.3 3.2 3.6 3.0 3.3 3.1 2.8 4.2 3.035 [1.62 .. 1.64] 1.3 1.5 1.3 1.4 1.4 1.5 1.4 1.5 1.5 1.5 1.5 1.6 1.4 1.5 1.4 1.5 1.9 1.436 [1.64 .. 1.66] 1.1 1.2 1.1 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.3 1.2 1.2 1.2 1.2 1.6 1.237 [1.66 .. 1.68] 1.1 1.2 1.1 1.2 1.1 1.2 1.2 1.2 1.2 1.2 1.2 1.3 1.2 1.2 1.2 1.3 1.6 1.238 [1.68 .. 1.74] 3.8 4.4 3.8 3.7 3.7 4.0 4.0 3.9 3.9 4.5 4.3 4.6 4.1 4.0 4.3 4.1 5.8 4.039 [1.74 .. 1.80] 3.4 3.8 3.4 3.2 3.3 3.4 3.6 3.5 3.6 3.8 3.8 4.0 3.6 3.6 3.7 3.5 4.9 3.540 [1.80 .. 1.82] 1.1 1.2 1.1 1.1 1.1 1.1 1.2 1.2 1.1 1.1 1.2 1.2 1.2 1.2 1.1 1.2 1.5 1.241 [1.82 .. 1.84] 1.0 1.1 1.1 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.2 1.1 1.1 1.1 1.2 1.5 1.142 [1.84 .. 1.86] 1.1 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.1 1.2 1.2 1.2 1.1 1.2 1.2 1.5 1.6 1.243 [1.86 .. 1.88] 1.1 1.2 1.2 1.3 1.2 1.2 1.4 1.3 1.2 1.3 1.2 1.3 1.2 1.3 1.3 1.5 1.7 1.344 [1.88 .. 1.94] 4.9 5.1 4.7 4.2 4.4 5.0 4.8 4.3 4.9 5.4 5.2 5.6 5.1 5.0 5.5 4.0 7.2 4.745 [1.94 .. 1.96] 1.5 1.6 1.4 1.3 1.3 1.4 1.3 1.3 1.4 1.5 1.5 1.6 1.4 1.4 1.3 1.3 1.8 1.346 [1.96 .. 1.98] 1.3 1.4 1.3 1.5 1.6 1.6 1.2 1.2 1.2 1.4 1.3 1.4 1.3 1.2 1.2 1.3 1.6 1.247 [1.98 .. 2.00] 1.7 1.8 1.6 2.2 2.6 2.0 1.5 1.5 1.5 1.8 1.5 1.7 1.7 1.5 1.5 1.6 2.0 1.648 [2.00 .. 2.06] 5.2 6.3 4.9 6.3 8.0 5.3 4.5 4.4 4.6 6.0 4.7 5.2 5.0 4.4 4.9 4.6 6.6 4.949 [2.06 .. 2.10] 3.0 3.6 3.0 3.2 3.4 3.3 3.3 3.2 3.1 3.7 3.3 3.5 3.1 3.1 3.5 3.5 4.5 3.550 [2.10 .. 2.13] 2.4 2.8 2.6 2.4 2.5 2.7 2.8 2.7 2.7 3.0 3.0 3.1 2.7 2.7 3.3 2.1 4.0 2.951 [2.13 .. 2.18] 6.0 6.5 5.5 7.3 8.1 11.1 5.9 8.1 6.8 6.4 6.7 7.1 6.5 7.2 6.0 5.2 8.3 5.952 [2.18 .. 2.21] 2.0 2.1 1.8 1.7 1.9 1.8 2.1 2.6 2.4 2.1 2.1 2.3 2.1 2.4 2.0 1.6 2.7 2.153 [2.21 .. 2.26] 4.5 5.4 4.6 4.3 5.0 4.0 4.4 4.1 4.5 5.5 4.6 5.4 4.6 4.6 4.7 3.7 6.4 4.354 [2.26 .. 2.31] 2.9 3.1 2.8 2.6 2.8 2.7 2.8 2.9 3.2 3.1 3.1 3.3 2.8 2.8 2.9 2.7 3.9 3.055 [2.31 .. 2.34] 2.4 2.4 2.2 2.1 2.1 2.2 2.4 2.6 2.8 2.3 2.6 2.6 2.2 2.3 2.2 2.2 3.2 2.656 [2.34 .. 2.36] 1.3 1.4 1.2 1.1 1.2 1.2 1.3 1.3 1.3 1.4 1.4 1.4 1.3 1.3 1.3 1.2 1.8 1.357 [2.36 .. 2.41] 3.4 3.5 3.3 3.2 3.2 3.4 3.4 3.6 3.9 3.5 3.8 3.9 3.2 3.4 3.4 3.5 4.6 3.658 [2.41 .. 2.47] 4.1 4.4 4.2 3.9 4.0 4.4 4.5 4.6 4.6 4.5 4.9 5.0 4.3 4.5 4.9 3.8 6.2 4.659 [2.47 .. 2.52] 3.0 3.2 3.0 2.7 2.8 2.7 3.0 2.9 3.4 3.2 3.4 3.6 2.9 3.2 3.1 2.8 4.0 2.960 [2.52 .. 2.58] 3.0 3.0 3.0 2.8 2.9 2.8 3.1 3.0 3.2 3.2 3.1 3.4 2.9 3.1 3.0 2.9 3.8 3.1
Data Processing/Reduction
Pathway Analysis
-0.1
0.0
0.1
0.2
[3.5
6 ..
3
[7.1
7 ..
7
[2.4
4 ..
2
[8.1
2 ..
8
[6.9
0 ..
6
[1.8
3 ..
1
[3.2
1 ..
3
[7.2
2 ..
7
[2.4
0 ..
2
[1.4
6 ..
1
[1.9
1 ..
1
[6.9
5 ..
7
[8.4
1 ..
8
Co
effC
S[2
](re
spo
nd
er
(<1
.5, >
2))
Var ID (Primary)
2 week APAP phar metab- 100 scaled.M8 (OPLS), OPLSDA- Day 5-6, 1.5 > ALT > 2.0CoeffCS[Last comp.](responder (<1.5, >2))
SIMCA-P+ 11.5 - 7/18/2007 3:46:31 PM
Identify Critical Metabolites
-10
-5
0
5
10
-40 -30 -20 -10 0 10 20 30 40
t[2]
t[1]SIMCA-P+ 11.5 - 7/11/2007 2:57:58 PM
Multivariate Statistics
Overall Process of Metabolomics Investigations
Acknowledgements
Metabolomics LabJohn Grimes
Wimal PathmasiriYi Shuai
Hamner-UNC Institute for Drug Safety Sciences
Paul Watkins